Cargando…

Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)

Acute lymphoblastic leukemia (ALL) represents the most common pediatric cancer. Most patients (85%) develop B-cell ALL; however, T-cell ALL tends to be more aggressive. We have previously identified 2B4 (SLAMF4), CS1 (SLAMF7) and LLT1 (CLEC2D) that can activate or inhibit NK cells upon the interacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powers, Sheila B., Ahmed, Nourhan G., Jose, Roslin, Brezgiel, Marissa, Aryal, Subhash, Bowman, W. Paul, Mathew, Porunelloor A., Mathew, Stephen O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959214/ https://www.ncbi.nlm.nih.gov/pubmed/36835271 http://dx.doi.org/10.3390/ijms24043860

Ejemplares similares

NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors
por: Horton, Nathan C., et al.
Publicado: (2015)

Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30
por: Luczo, Jasmina M., et al.
Publicado: (2021)

The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s
por: Sheppard, Sam, et al.
Publicado: (2018)

NKp46 regulates allergic responses
por: Ghadially, Hormas, et al.
Publicado: (2013)

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
por: Jarahian, Mostafa, et al.
Publicado: (2011)

A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells
por: Bowen, Kelly E., et al.
Publicado: (2018)

Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
por: Byrd, Andreina, et al.
Publicado: (2007)

Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer
por: Buller, Casey W., et al.
Publicado: (2020)

Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)
por: Glasner, Ariella, et al.
Publicado: (2017)

NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
por: Ghadially, Hormas, et al.
Publicado: (2014)

Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells
por: Marafini, Irene, et al.
Publicado: (2016)

Porcine Plasmacytoid Dendritic Cells Are Unique in Their Expression of a Functional NKp46 Receptor
por: Mair, Kerstin H., et al.
Publicado: (2022)

MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
por: Pan, Chenwei, et al.
Publicado: (2018)

Dependence of innate lymphoid cell 1 development on NKp46
por: Wang, Yufeng, et al.
Publicado: (2018)

Altered NKp46 Recognition and Elimination of Influenza B Viruses
por: Duev-Cohen, Alexandra, et al.
Publicado: (2020)

Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44
por: Horton, Nathan C., et al.
Publicado: (2013)

Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction
por: Mathew, Stephen O., et al.
Publicado: (2016)

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
por: Garcia-Iglesias, Trinidad, et al.
Publicado: (2009)

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization
por: Hadad, Uzi, et al.
Publicado: (2015)

The Natural Cytotoxicity Receptor NKp44 (NCR2, CD336) Is Expressed on the Majority of Porcine NK Cells Ex Vivo Without Stimulation
por: Mair, Kerstin H., et al.
Publicado: (2022)

Functional Differences between Human NKp44(−) and NKp44(+) RORC(+) Innate Lymphoid Cells
por: Hoorweg, Kerim, et al.
Publicado: (2012)

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort
por: Prada, Nicole, et al.
Publicado: (2013)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

NKp46 defines ovine cells that have characteristics corresponding to NK cells
por: Connelley, Timothy, et al.
Publicado: (2011)

Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues
por: Tomasello, Elena, et al.
Publicado: (2012)

Unique and redundant functions of NKp46(+) ILC3s in models of intestinal inflammation
por: Song, Christina, et al.
Publicado: (2015)

WASH maintains NKp46(+) ILC3 cells by promoting AHR expression
por: Xia, Pengyan, et al.
Publicado: (2017)

Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease
por: Chaushu, Stella, et al.
Publicado: (2012)

The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes
por: Gur, Chamutal, et al.
Publicado: (2013)

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
por: Shemesh, Avishai, et al.
Publicado: (2016)

Role of NKp46(+) natural killer cells in house dust mite‐driven asthma
por: Haspeslagh, Eline, et al.
Publicado: (2018)

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
por: Glasner, Ariella, et al.
Publicado: (2017)

Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
por: Yoshioka, Teppei, et al.
Publicado: (2017)

Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation
por: Elhmouzi-Younes, Jamila, et al.
Publicado: (2009)

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
por: Parodi, Monica, et al.
Publicado: (2019)

Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
por: Gaggero, Silvia, et al.
Publicado: (2018)

Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity
por: Pessino, Anna, et al.
Publicado: (1998)

A novel mucosal RORγt(+)NKp46(+) cell subset is a source of interleukin-22
por: Tomasello, Elena, et al.
Publicado: (2009)

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
por: Yossef, Rami, et al.
Publicado: (2015)

Zbtb1 controls NKp46(+) ROR-gamma-T(+) innate lymphoid cell (ILC3) development
por: Lu, Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_35dq0p8satk4lqh7opi9ci12v5